Last 12 months
Inside the activity.
0 purchase rows · 31 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 11 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 15 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 3 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 15, 2017 Filed Mar 1, 2017 22:27 UTC |
Skoufalos IoannisGlobal Product Supply Officer
|
GrantRestricted Stock Units · Derivative | 40.008 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-009350 · form4.xml · derivative · entry 3 Skoufalos Ioannis · CIK 0001525333 · Global Product Supply Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 465.708 Underlying: Common Stock · 40.008 shares Expires not disclosed F3 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F4 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F4 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| February 15, 2017 Filed Mar 1, 2017 22:28 UTC |
Suranjan MagesvaranPresident - Asia Pacific SMO
|
GrantRestricted Stock Units · Derivative | 3.52 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-009351 · form4.xml · derivative · entry 3 Magesvaran Suranjan · CIK 0001657274 · President - Asia Pacific SMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7.311 Underlying: Common Stock · 3.52 shares Expires not disclosed F2 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F3 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F3 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| February 15, 2017 Filed Mar 1, 2017 22:30 UTC |
Posada Juan FernandoPresident - LA SMO
|
GrantRestricted Stock Units · Derivative | 3.528 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-009354 · form4.xml · derivative · entry 5 Posada Juan Fernando · CIK 0001653283 · President - LA SMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7.327 Underlying: Common Stock · 3.528 shares Expires not disclosed F2 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F3 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F3 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| February 15, 2017 Filed Mar 1, 2017 22:31 UTC |
Taylor David SDirector · President & CEO
|
GrantRestricted Stock Units · Derivative | 31.564 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-009355 · form4.xml · derivative · entry 3 Taylor David S · CIK 0001505989 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120.862 Underlying: Common Stock · 31.564 shares Expires not disclosed F3 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F4 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F4 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| February 15, 2017 Filed Mar 1, 2017 22:33 UTC |
TASTAD CAROLYN MGroup President - NA SMO
|
GrantRestricted Stock Units · Derivative | 15.533 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-009358 · form4.xml · derivative · entry 6 TASTAD CAROLYN M · CIK 0001597938 · Group President - NA SMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89.127 Underlying: Common Stock · 15.533 shares Expires not disclosed F4 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F5 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F5 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| February 15, 2017 Filed Mar 1, 2017 22:34 UTC |
Coombe Gary APresident-Europe SMO
|
GrantRestricted Stock Units · Derivative | 10.052 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-009360 · form4.xml · derivative · entry 3 Coombe Gary A · CIK 0001623622 · President-Europe SMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46.748 Underlying: Common Stock · 10.052 shares Expires not disclosed F1 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F2 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F2 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| February 15, 2017 Filed Mar 1, 2017 22:35 UTC |
Louvet PatriceGroup President, Global Beauty
|
GrantRestricted Stock Units · Derivative | 51.497 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-009362 · form4.xml · derivative · entry 3 Louvet Patrice · CIK 0001669213 · Group President, Global Beauty 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 199.347 Underlying: Common Stock · 51.497 shares Expires not disclosed F3 · derivative.exercise_price: Dividend equivalents in the form of Retirement Restricted Stock Units (RSUs) previously awarded pursuant to Issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock or cash settlement. F4 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F4 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| February 15, 2017 Filed Mar 1, 2017 22:38 UTC |
Giovanni CiseraniGrpPres-Global F&HC,Baby&Fem
|
GrantRestricted Stock Units · Derivative | 138.417 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-009367 · form4.xml · derivative · entry 2 Giovanni Ciserani · CIK 0001580892 · GrpPres-Global F&HC,Baby&Fem 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,690.215 Underlying: Common Stock · 138.417 shares Expires not disclosed F1 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F2 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F2 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| February 15, 2017 Filed Mar 2, 2017 17:47 UTC |
Bishop Steven DGroup President Global Health
|
GrantRestricted Stock Units · Derivative | 83.901 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-009515 · form4.xml · derivative · entry 4 Bishop Steven D · CIK 0001669212 · Group President Global Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 331.793 Underlying: Common Stock · 83.901 shares Expires not disclosed F3 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F4 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F4 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| February 14, 2017 Filed Feb 15, 2017 14:10 UTC |
Louvet PatriceGroup President, Global Beauty
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 56,935 | $0.00 Strike: $48.17 | $0.00 |
DisclosureSEC source: 0001127602-17-006173 · form4.xml · derivative · entry 6 Louvet Patrice · CIK 0001669213 · Group President, Global Beauty 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 56,935 shares Expires 2019-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 14, 2017 Filed Feb 15, 2017 14:10 UTC |
Louvet PatriceGroup President, Global Beauty
|
SaleCommon Stock | 56,935 | $87.94 | $5,006,732.95 |
DisclosureSEC source: 0001127602-17-006173 · form4.xml · nonDerivative · entry 2 Louvet Patrice · CIK 0001669213 · Group President, Global Beauty 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,838.006 F1 · price: Weighted average price of the shares sold. The price range was $87.72 to $88.02. Full information regarding the number of shares sold at each separate price available upon request. Read SEC document |
| February 14, 2017 Filed Feb 15, 2017 14:10 UTC |
Louvet PatriceGroup President, Global Beauty
|
Exercise / conversionCommon Stock | 56,935 | $48.17 | $2,742,558.95 |
DisclosureSEC source: 0001127602-17-006173 · form4.xml · nonDerivative · entry 1 Louvet Patrice · CIK 0001669213 · Group President, Global Beauty 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,773.006 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 09, 2017 Filed Feb 10, 2017 16:41 UTC |
Taylor David SDirector · President & CEO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 38,000 | $0.00 Strike: $63.28 | $0.00 |
DisclosureSEC source: 0001127602-17-004927 · form4.xml · derivative · entry 6 Taylor David S · CIK 0001505989 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,113 Underlying: Common Stock · 38,000 shares Expires 2020-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 09, 2017 Filed Feb 10, 2017 16:41 UTC |
Taylor David SDirector · President & CEO
|
SaleCommon Stock | 38,000 | $88.55 | $3,364,873.40 |
DisclosureSEC source: 0001127602-17-004927 · form4.xml · nonDerivative · entry 2 Taylor David S · CIK 0001505989 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,038.5464 F2 · price: Weighted average price of the shares sold. The price range was $88.51 to $88.605. Full information regarding the number of shares sold at each separate price available upon request. Read SEC document |
| February 09, 2017 Filed Feb 10, 2017 16:41 UTC |
Taylor David SDirector · President & CEO
|
Exercise / conversionCommon Stock | 38,000 | $63.28 | $2,404,640.00 |
DisclosureSEC source: 0001127602-17-004927 · form4.xml · nonDerivative · entry 1 Taylor David S · CIK 0001505989 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,038.5464 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock. Read SEC document |
| February 09, 2017 Filed Feb 10, 2017 16:43 UTC |
Skoufalos IoannisGlobal Product Supply Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $63.28 | $0.00 |
DisclosureSEC source: 0001127602-17-004928 · form4.xml · derivative · entry 4 Skoufalos Ioannis · CIK 0001525333 · Global Product Supply Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2020-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 09, 2017 Filed Feb 10, 2017 16:43 UTC |
Skoufalos IoannisGlobal Product Supply Officer
|
SaleCommon Stock | 10,000 | $88.65 | $886,501.00 |
DisclosureSEC source: 0001127602-17-004928 · form4.xml · nonDerivative · entry 2 Skoufalos Ioannis · CIK 0001525333 · Global Product Supply Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,922.2441 F1 · price: Weighted average price of the shares sold. The price range was $88.65 to $88.655. Full information regarding the number of shares sold at each separate price available upon request. Read SEC document |
| February 09, 2017 Filed Feb 10, 2017 16:43 UTC |
Skoufalos IoannisGlobal Product Supply Officer
|
Exercise / conversionCommon Stock | 10,000 | $63.28 | $632,800.00 |
DisclosureSEC source: 0001127602-17-004928 · form4.xml · nonDerivative · entry 1 Skoufalos Ioannis · CIK 0001525333 · Global Product Supply Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,922.2441 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 02, 2017 Filed Feb 3, 2017 18:01 UTC |
Posada Juan FernandoPresident - LA SMO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $63.49 | $0.00 |
DisclosureSEC source: 0001127602-17-003806 · form4.xml · derivative · entry 5 Posada Juan Fernando · CIK 0001653283 · President - LA SMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2017-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 02, 2017 Filed Feb 3, 2017 18:01 UTC |
Posada Juan FernandoPresident - LA SMO
|
SaleCommon Stock | 5,000 | $88.00 | $440,000.00 |
DisclosureSEC source: 0001127602-17-003806 · form4.xml · nonDerivative · entry 2 Posada Juan Fernando · CIK 0001653283 · President - LA SMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,988.5041 Read SEC document |
| February 02, 2017 Filed Feb 3, 2017 18:01 UTC |
Posada Juan FernandoPresident - LA SMO
|
Exercise / conversionCommon Stock | 5,000 | $63.49 | $317,450.00 |
DisclosureSEC source: 0001127602-17-003806 · form4.xml · nonDerivative · entry 1 Posada Juan Fernando · CIK 0001653283 · President - LA SMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,988.5041 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 02, 2017 Filed Feb 3, 2017 18:03 UTC |
TASTAD CAROLYN MGroup President - NA SMO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 21,836 | $0.00 Strike: $66.18 | $0.00 |
DisclosureSEC source: 0001127602-17-003807 · form4.xml · derivative · entry 13 TASTAD CAROLYN M · CIK 0001597938 · Group President - NA SMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 21,836 shares Expires 2018-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 02, 2017 Filed Feb 3, 2017 18:03 UTC |
TASTAD CAROLYN MGroup President - NA SMO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 3,504 | $0.00 Strike: $67.81 | $0.00 |
DisclosureSEC source: 0001127602-17-003807 · form4.xml · derivative · entry 12 TASTAD CAROLYN M · CIK 0001597938 · Group President - NA SMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,504 shares Expires 2017-09-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 02, 2017 Filed Feb 3, 2017 18:03 UTC |
TASTAD CAROLYN MGroup President - NA SMO
|
SaleCommon Stock | 4,879 | $88.00 | $429,352.00 |
DisclosureSEC source: 0001127602-17-003807 · form4.xml · nonDerivative · entry 6 TASTAD CAROLYN M · CIK 0001597938 · Group President - NA SMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,419.137 Read SEC document |
| February 02, 2017 Filed Feb 3, 2017 18:03 UTC |
TASTAD CAROLYN MGroup President - NA SMO
|
SaleCommon Stock | 21,836 | $88.00 | $1,921,568.00 |
DisclosureSEC source: 0001127602-17-003807 · form4.xml · nonDerivative · entry 5 TASTAD CAROLYN M · CIK 0001597938 · Group President - NA SMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,298.137 Read SEC document |
| February 02, 2017 Filed Feb 3, 2017 18:03 UTC |
TASTAD CAROLYN MGroup President - NA SMO
|
Exercise / conversionCommon Stock | 21,836 | $66.18 | $1,445,106.48 |
DisclosureSEC source: 0001127602-17-003807 · form4.xml · nonDerivative · entry 4 TASTAD CAROLYN M · CIK 0001597938 · Group President - NA SMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,134.137 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 02, 2017 Filed Feb 3, 2017 18:03 UTC |
TASTAD CAROLYN MGroup President - NA SMO
|
SaleCommon Stock | 3,504 | $88.00 | $308,352.00 |
DisclosureSEC source: 0001127602-17-003807 · form4.xml · nonDerivative · entry 3 TASTAD CAROLYN M · CIK 0001597938 · Group President - NA SMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,298.137 Read SEC document |
| February 02, 2017 Filed Feb 3, 2017 18:03 UTC |
TASTAD CAROLYN MGroup President - NA SMO
|
Exercise / conversionCommon Stock | 3,504 | $67.81 | $237,606.24 |
DisclosureSEC source: 0001127602-17-003807 · form4.xml · nonDerivative · entry 2 TASTAD CAROLYN M · CIK 0001597938 · Group President - NA SMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,802.137 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2017 Filed Feb 3, 2017 17:59 UTC |
Biegger Mark FChief Human Resources Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 13,790 | $0.00 Strike: $48.17 | $0.00 |
DisclosureSEC source: 0001127602-17-003805 · form4.xml · derivative · entry 10 Biegger Mark F · CIK 0001557671 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 13,790 shares Expires 2019-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2017 Filed Feb 3, 2017 17:59 UTC |
Biegger Mark FChief Human Resources Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 17,326 | $0.00 Strike: $66.18 | $0.00 |
DisclosureSEC source: 0001127602-17-003805 · form4.xml · derivative · entry 9 Biegger Mark F · CIK 0001557671 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 17,326 shares Expires 2018-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2017 Filed Feb 3, 2017 17:59 UTC |
Biegger Mark FChief Human Resources Officer
|
SaleCommon Stock | 13,790 | $87.45 | $1,205,866.55 |
DisclosureSEC source: 0001127602-17-003805 · form4.xml · nonDerivative · entry 4 Biegger Mark F · CIK 0001557671 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,501.315 F2 · price: Weighted average price of the shares sold. The price range was $87.415 to $87.49. Full information regarding the number of shares sold at each separate price available upon request. Read SEC document |
| February 01, 2017 Filed Feb 3, 2017 17:59 UTC |
Biegger Mark FChief Human Resources Officer
|
Exercise / conversionCommon Stock | 13,790 | $48.17 | $664,264.30 |
DisclosureSEC source: 0001127602-17-003805 · form4.xml · nonDerivative · entry 3 Biegger Mark F · CIK 0001557671 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,291.315 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2017 Filed Feb 3, 2017 17:59 UTC |
Biegger Mark FChief Human Resources Officer
|
SaleCommon Stock | 17,326 | $87.45 | $1,515,072.07 |
DisclosureSEC source: 0001127602-17-003805 · form4.xml · nonDerivative · entry 2 Biegger Mark F · CIK 0001557671 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,501.315 F2 · price: Weighted average price of the shares sold. The price range was $87.415 to $87.49. Full information regarding the number of shares sold at each separate price available upon request. Read SEC document |
| February 01, 2017 Filed Feb 3, 2017 17:59 UTC |
Biegger Mark FChief Human Resources Officer
|
Exercise / conversionCommon Stock | 17,326 | $66.18 | $1,146,634.68 |
DisclosureSEC source: 0001127602-17-003805 · form4.xml · nonDerivative · entry 1 Biegger Mark F · CIK 0001557671 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,827.315 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock. Read SEC document |
| January 31, 2017 Filed Jan 31, 2017 18:25 UTC |
Skoufalos IoannisGlobal Product Supply Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $63.28 | $0.00 |
DisclosureSEC source: 0001127602-17-003039 · form4.xml · derivative · entry 6 Skoufalos Ioannis · CIK 0001525333 · Global Product Supply Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2020-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 31, 2017 Filed Jan 31, 2017 18:25 UTC |
Skoufalos IoannisGlobal Product Supply Officer
|
SaleCommon Stock | 10,000 | $87.00 | $870,000.00 |
DisclosureSEC source: 0001127602-17-003039 · form4.xml · nonDerivative · entry 2 Skoufalos Ioannis · CIK 0001525333 · Global Product Supply Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,922.2441 Read SEC document |
| January 31, 2017 Filed Jan 31, 2017 18:25 UTC |
Skoufalos IoannisGlobal Product Supply Officer
|
Exercise / conversionCommon Stock | 10,000 | $63.28 | $632,800.00 |
DisclosureSEC source: 0001127602-17-003039 · form4.xml · nonDerivative · entry 1 Skoufalos Ioannis · CIK 0001525333 · Global Product Supply Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,922.2441 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSUs) settled in common stock. Read SEC document |
| January 30, 2017 Filed Jan 31, 2017 17:13 UTC |
Posada Juan FernandoPresident - LA SMO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 7,000 | $0.00 Strike: $63.49 | $0.00 |
DisclosureSEC source: 0001127602-17-003022 · form4.xml · derivative · entry 6 Posada Juan Fernando · CIK 0001653283 · President - LA SMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 7,000 shares Expires 2017-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 30, 2017 Filed Jan 31, 2017 17:13 UTC |
Posada Juan FernandoPresident - LA SMO
|
SaleCommon Stock | 7,000 | $86.75 | $607,250.00 |
DisclosureSEC source: 0001127602-17-003022 · form4.xml · nonDerivative · entry 2 Posada Juan Fernando · CIK 0001653283 · President - LA SMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,988.5041 Read SEC document |
| January 30, 2017 Filed Jan 31, 2017 17:13 UTC |
Posada Juan FernandoPresident - LA SMO
|
Exercise / conversionCommon Stock | 7,000 | $63.49 | $444,430.00 |
DisclosureSEC source: 0001127602-17-003022 · form4.xml · nonDerivative · entry 1 Posada Juan Fernando · CIK 0001653283 · President - LA SMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,988.5041 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 24, 2017 Filed Jan 25, 2017 14:13 UTC |
Schomburger Jeffrey KGlobal Sales Officer, CBD
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 36,227 | $0.00 Strike: $63.49 | $0.00 |
DisclosureSEC source: 0001127602-17-002307 · form4.xml · derivative · entry 6 Schomburger Jeffrey K · CIK 0001630117 · Global Sales Officer, CBD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 36,227 shares Expires 2017-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 24, 2017 Filed Jan 25, 2017 14:13 UTC |
Schomburger Jeffrey KGlobal Sales Officer, CBD
|
SaleCommon Stock | 36,227 | $87.50 | $3,169,862.50 |
DisclosureSEC source: 0001127602-17-002307 · form4.xml · nonDerivative · entry 2 Schomburger Jeffrey K · CIK 0001630117 · Global Sales Officer, CBD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,210.948 Read SEC document |
| January 24, 2017 Filed Jan 25, 2017 14:13 UTC |
Schomburger Jeffrey KGlobal Sales Officer, CBD
|
Exercise / conversionCommon Stock | 36,227 | $63.49 | $2,300,052.23 |
DisclosureSEC source: 0001127602-17-002307 · form4.xml · nonDerivative · entry 1 Schomburger Jeffrey K · CIK 0001630117 · Global Sales Officer, CBD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,437.948 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSUs) settled in common stock. Read SEC document |
| January 23, 2017 Filed Jan 23, 2017 21:02 UTC |
Pritchard Marc S.Chief Brand Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 47,252 | $0.00 Strike: $63.49 | $0.00 |
DisclosureSEC source: 0001127602-17-002223 · form4.xml · derivative · entry 10 Pritchard Marc S. · CIK 0001440364 · Chief Brand Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 47,252 shares Expires 2017-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 23, 2017 Filed Jan 23, 2017 21:02 UTC |
Pritchard Marc S.Chief Brand Officer
|
SaleCommon Stock | 47,252 | $87.14 | $4,117,539.28 |
DisclosureSEC source: 0001127602-17-002223 · form4.xml · nonDerivative · entry 2 Pritchard Marc S. · CIK 0001440364 · Chief Brand Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,390.5373 F1 · price: Weighted average price of the shares sold. The price range was $87.08 to $87.22. Full information regarding the number of shares sold at each separate price available upon request. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock. Read SEC document |
| January 23, 2017 Filed Jan 23, 2017 21:02 UTC |
Pritchard Marc S.Chief Brand Officer
|
Exercise / conversionCommon Stock | 47,252 | $63.49 | $3,000,029.48 |
DisclosureSEC source: 0001127602-17-002223 · form4.xml · nonDerivative · entry 1 Pritchard Marc S. · CIK 0001440364 · Chief Brand Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 151,642.5373 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 23, 2017 Filed Jan 23, 2017 21:05 UTC |
Sheppard Valarie LSr VP, Comptroller & Treasurer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 20,910 | $0.00 Strike: $63.49 | $0.00 |
DisclosureSEC source: 0001127602-17-002224 · form4.xml · derivative · entry 5 Sheppard Valarie L · CIK 0001334175 · Sr VP, Comptroller & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,910 shares Expires 2017-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 23, 2017 Filed Jan 23, 2017 21:05 UTC |
Sheppard Valarie LSr VP, Comptroller & Treasurer
|
SaleCommon Stock | 20,910 | $87.00 | $1,819,170.00 |
DisclosureSEC source: 0001127602-17-002224 · form4.xml · nonDerivative · entry 2 Sheppard Valarie L · CIK 0001334175 · Sr VP, Comptroller & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,925.435 F1 · price: Weighted average price of the shares sold. The price range was $86.995 to $87.02. Full information regarding the number of shares sold at each separate price available upon request. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSUs) settled in common stock. Read SEC document |
| January 23, 2017 Filed Jan 23, 2017 21:05 UTC |
Sheppard Valarie LSr VP, Comptroller & Treasurer
|
Exercise / conversionCommon Stock | 20,910 | $63.49 | $1,327,575.90 |
DisclosureSEC source: 0001127602-17-002224 · form4.xml · nonDerivative · entry 1 Sheppard Valarie L · CIK 0001334175 · Sr VP, Comptroller & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,835.435 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 23, 2017 Filed Jan 25, 2017 13:25 UTC |
Bishop Steven DGroup President Global Health
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 47,748 | $0.00 Strike: $48.17 | $0.00 |
DisclosureSEC source: 0001127602-17-002305 · form4.xml · derivative · entry 11 Bishop Steven D · CIK 0001669212 · Group President Global Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 47,748 shares Expires 2019-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.